Histopathological Characteristics of IV Recombinant Tissue Plasminogen -Resistant Thrombi in Patients with Acute Ischemic Stroke.
作者信息
Qureshi Adnan I, Qureshi Mushtaq H, Lobanova Iryna, Bashir Asif, Khan Asif A, Bologna Stephen M, Peterson Michelle, Suri M Fareed K
机构信息
Zeenat Qureshi Stroke Institute, St Cloud, MN, and CentraCare Health, St. Cloud, MN, USA.
JFK New Jersey Neuroscience Institute at Seton Hall University, Edison, NJ, USA.
出版信息
J Vasc Interv Neurol. 2016 Jan;8(5):38-45.
Abstract
摘要
相似文献
1
Histopathological Characteristics of IV Recombinant Tissue Plasminogen -Resistant Thrombi in Patients with Acute Ischemic Stroke.急性缺血性脑卒中患者静脉注射重组组织型纤溶酶原抵抗性血栓的组织病理学特征
J Vasc Interv Neurol. 2016 Jan;8(5):38-45.
2
Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.静脉注射重组组织型纤溶酶原激活剂治疗急性缺血性卒中的真实世界结局
J Stroke Cerebrovasc Dis. 2017 Sep;26(9):1996-2003. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.010. Epub 2017 Jul 6.
3
In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy?在有吸烟发生率的急性缺血性中风患者中，女性比男性更有可能被纳入或排除在溶栓治疗之外吗？
Womens Health (Lond). 2020 Jan-Dec;16:1745506520922760. doi: 10.1177/1745506520922760.
4
Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.急性缺血性卒中中联合静脉和动脉溶栓与使用重组组织型纤溶酶原激活剂进行原发性动脉治疗的比较。
J Stroke Cerebrovasc Dis. 2008 May-Jun;17(3):121-8. doi: 10.1016/j.jstrokecerebrovasdis.2007.12.004.
5
Potent Thrombolytic Effect of -Acetylcysteine on Arterial Thrombi.-乙酰半胱氨酸对动脉血栓的强效溶栓作用。
Circulation. 2017 Aug 15;136(7):646-660. doi: 10.1161/CIRCULATIONAHA.117.027290. Epub 2017 May 9.
6
Relationship between hospital volume and early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.接受重组组织型纤溶酶原激活剂治疗的急性缺血性卒中患者的医院治疗量与早期预后的关系
Int J Stroke. 2015 Jan;10(1):73-8. doi: 10.1111/ijs.12311. Epub 2014 Jul 18.
7
Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?急性缺血性卒中患者在接受全剂量静脉注射重组组织型纤溶酶原激活剂后，动脉内溶栓是否安全？
Stroke. 2007 Jan;38(1):80-4. doi: 10.1161/01.STR.0000251720.25337.b0. Epub 2006 Nov 22.
8
Recombinant tissue plasminogen activator for acute ischemic stroke.重组组织型纤溶酶原激活剂用于急性缺血性卒中
Neurosciences (Riyadh). 2002 Jan;7(1):7-13.
9
Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.在急性缺血性中风患者中，可渗透血栓与静脉注射重组组织型纤溶酶原激活剂治疗成功率较高相关。
Stroke. 2016 Aug;47(8):2058-65. doi: 10.1161/STROKEAHA.116.013306. Epub 2016 Jun 23.
10
Thromboembolic Complications Following Tissue Plasminogen Activator Therapy in Patients of Acute Ischemic Stroke - Case Report and Possibility for Detection of Cardiac Thrombi.急性缺血性脑卒中患者组织型纤溶酶原激活剂治疗后的血栓栓塞并发症——病例报告及心脏血栓检测的可能性
Open Med (Wars). 2018 Nov 19;13:551-555. doi: 10.1515/med-2018-0081. eCollection 2018.
引用本文的文献
1
Thrombus age does not differentiate between cardiogenic and atherosclerotic strokes.血栓形成时间无法区分心源性中风和动脉粥样硬化性中风。
BMJ Neurol Open. 2024 Jul 5;6(2):e000724. doi: 10.1136/bmjno-2024-000724. eCollection 2024.
2
Deep learning prediction of stroke thrombus red blood cell content from multiparametric MRI.基于多参数 MRI 的深度学习预测脑卒中血栓中红细胞含量
Interv Neuroradiol. 2024 Aug;30(4):541-549. doi: 10.1177/15910199221140962. Epub 2022 Nov 28.
3
Clot Composition Analysis as a Diagnostic Tool to Gain Insight into Ischemic Stroke Etiology: A Systematic Review.凝血块成分分析作为深入了解缺血性中风病因的诊断工具：一项系统综述
J Stroke. 2021 Sep;23(3):327-342. doi: 10.5853/jos.2021.02306. Epub 2021 Sep 30.
4
Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window.阿替普酶溶栓治疗二十五周年：治疗窗的演变
Front Neurol. 2021 Mar 1;12:593887. doi: 10.3389/fneur.2021.593887. eCollection 2021.
5
Pathophysiologic and Therapeutic Perspectives Based on Thrombus Histology in Stroke.基于血栓组织学的中风病理生理学与治疗前景
J Stroke. 2020 Jan;22(1):64-75. doi: 10.5853/jos.2019.03440. Epub 2020 Jan 31.
6
Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis.急性缺血性脑卒中血栓的外壳可阻碍纤维蛋白溶解。
Neurology. 2019 Oct 29;93(18):e1686-e1698. doi: 10.1212/WNL.0000000000008395. Epub 2019 Sep 20.
7
Insights from thrombi retrieved in stroke due to large vessel occlusion.大血管闭塞性脑卒中血栓取出术中的新发现。
J Cereb Blood Flow Metab. 2019 Aug;39(8):1433-1451. doi: 10.1177/0271678X19856131. Epub 2019 Jun 18.
8
Platelet-rich clots as identified by Martius Scarlet Blue staining are isodense on NCCT.马蒂斯染色（Martius Scarlet Blue staining）识别的富血小板性血栓在 NCCT 上呈等密度。
J Neurointerv Surg. 2019 Nov;11(11):1145-1149. doi: 10.1136/neurintsurg-2018-014637. Epub 2019 Apr 5.
9
Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome.急性缺血性卒中血栓的影像学与组织病理学相关性及其病因和预后
J Neurosurg Sci. 2019 Jun;63(3):292-300. doi: 10.23736/S0390-5616.18.04629-5. Epub 2018 Dec 5.
10
Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review.急性缺血性卒中血栓的影像学与组织病理学相关性及其病因和预后：一项系统评价
J Neurointerv Surg. 2017 Jun;9(6):529-534. doi: 10.1136/neurintsurg-2016-012391. Epub 2016 May 10.
本文引用的文献
1
Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial.在卒中介入管理III期试验中，基线CT血管造影时闭塞部位的再通情况及临床结局。
Radiology. 2014 Oct;273(1):202-10. doi: 10.1148/radiol.14132649. Epub 2014 Jun 5.
2
Thrombus composition in acute ischemic stroke: a histopathological study of thrombus extracted by endovascular retrieval.急性缺血性卒中的血栓成分：一项关于血管内取栓所获血栓的组织病理学研究
J Neuroradiol. 2015 Apr;42(2):86-92. doi: 10.1016/j.neurad.2014.01.124. Epub 2014 Feb 20.
3
Histopathologic composition of cerebral thrombi of acute stroke patients is correlated with stroke subtype and thrombus attenuation.急性中风患者脑栓子的组织病理学构成与中风亚型及栓子密度相关。
PLoS One. 2014 Feb 11;9(2):e88882. doi: 10.1371/journal.pone.0088882. eCollection 2014.
4
Interaction of red blood cells adjacent to and within a thrombus in experimental cerebral ischaemia.实验性脑缺血时血栓中及毗邻的红细胞相互作用。
Thromb Res. 2013;132(6):718-23. doi: 10.1016/j.thromres.2013.08.024. Epub 2013 Oct 25.
5
Immunohistochemical analysis of thrombi retrieved during treatment of acute ischemic stroke: does stent-retriever cause intimal damage?急性缺血性脑卒中治疗期间取栓的血栓免疫组化分析：支架取栓是否会导致内膜损伤？
Stroke. 2013 Jun;44(6):1720-2. doi: 10.1161/STROKEAHA.113.000964. Epub 2013 May 14.
6
7
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.急性缺血性脑卒中患者早期管理指南：美国心脏协会/美国卒中协会医疗保健专业人员指南。
Stroke. 2013 Mar;44(3):870-947. doi: 10.1161/STR.0b013e318284056a. Epub 2013 Jan 31.
8
Subarachnoid hemorrhage in a multimodal approach heavily weighted toward mechanical thrombectomy with solitaire stent in acute stroke.蛛网膜下腔出血在急性脑卒中的机械取栓中采用Solitaire 支架的多模态治疗方法中占很大比重。
Stroke. 2013 Feb;44(2):414-9. doi: 10.1161/STROKEAHA.112.675546. Epub 2013 Jan 3.
9
Microcatheter to recanalization (procedure time) predicts outcomes in endovascular treatment in patients with acute ischemic stroke: when do we stop?微导管再通（操作时间）预测急性缺血性脑卒中患者血管内治疗的结局：我们何时停止？
AJNR Am J Neuroradiol. 2013 Feb;34(2):354-9. doi: 10.3174/ajnr.A3202. Epub 2012 Jul 19.
10
Recanalization following various endovascular modalities for treatment of anterior circulation acute ischemic strokes.用于治疗前循环急性缺血性卒中的各种血管内治疗方式后的再通情况。
J Vasc Interv Neurol. 2012 Jun;5(1):10-6.
Zotero 插件